Neon Therapeutics, Inc. — Form D/A
Neon Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2017-12-13. The offering totals $106.0M, of which $106.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-12-13
- Form: D/A
- Accession: 0001721811-17-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $106.0M
- Amount sold: $106.0M
- Remaining: $5
- Investors: 25
- Date of first sale: 2016-12-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278190
Issuer
- Name: Neon Therapeutics, Inc.
- CIK: 0001694187
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 40 ERIE STREET, CAMBRIDGE, MA, 02139
- Phone: 617-337-4701
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Hugh Dowd | Director | Cambridge, MA |
| Robert Kamen | Director | Cambridge, MA |
| Eric Lander | Director | Cambridge, MA |
| Cary Pfeffer, M.D. | Director | Cambridge, MA |
| Stephen Sherwin | Director | CAMBRIDGE, MA |
| Robert Tepper | Director | Cambridge, MA |
| Yasir Al-Wakeel | Executive Officer | Cambridge, MA |
| Robert Ang, M.D. | Executive Officer | Cambridge, MA |
| Hugh Dowd | Executive Officer | Cambridge, MA |
| Richard Gaynor, M.D. | Executive Officer | Cambridge, MA |
| Daniella Beckman | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More